Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04026581 · ClinicalTrials.gov registry record
Real World Testing of a Brain-Computer Interface
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 19
- Enrollment target
NCT04026581: Completed study, sponsored by University of Pittsburgh.
NCT04026581 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04026581 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
The goal of this project is to test a new AAC-BCI device comparing gel and dry electrode headgear used for communication while providing clinical care. Innovative resources will be employed to support the standard of care without considering limitations based on service billing codes. Clinical services will include AAC assessment, AAC-BCI device and treatment to individuals with minimal movement due to amyotrophic lateral sclerosis (ALS), brain stem strokes, severe cerebral palsy, traumatic brain injury (TBI) and their family support person. This is a descriptive study designed to measure and monitor the communication performance of individuals using the AAC-BCI, any other AAC strategies, their user satisfaction and perceptions of communication effectiveness, and the satisfaction of the family support persons.
Primary Outcome
Monitoring daily use of a speech generating device (SGD) for communication. Average communication rate based on total number of words used during the day.
Interventions
- BEHAVIORAL Speech generating device (SGD) evaluation including BCI access
- BEHAVIORAL Training and treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2019-06-05 |
| Est. Completion | 2023-09-30 |
What the finished NCT04026581 record still lists
NCT04026581 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Speech generating device (SGD) evaluation including BCI access is the first listed.
NCT04026581 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04026581 about?
NCT04026581 is a clinical study titled "Real World Testing of a Brain-Computer Interface". The goal of this project is to test a new AAC-BCI device comparing gel and dry electrode headgear used for communication while providing clinical care. Innovative resources will be employed to support the standard of care without considering limitations based on service billing codes. Clinical servi...
What is the current status of trial NCT04026581?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2019-06-05. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT04026581?
The interventions under investigation include: Speech generating device (SGD) evaluation including BCI access (BEHAVIORAL), Training and treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT04026581?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI